BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21148747)

  • 1. Both gene amplification and allelic loss occur at 14q13.3 in lung cancer.
    Harris T; Pan Q; Sironi J; Lutz D; Tian J; Sapkar J; Perez-Soler R; Keller S; Locker J
    Clin Cancer Res; 2011 Feb; 17(4):690-9. PubMed ID: 21148747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer.
    Kendall J; Liu Q; Bakleh A; Krasnitz A; Nguyen KC; Lakshmi B; Gerald WL; Powers S; Mu D
    Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16663-8. PubMed ID: 17925434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
    Lin L; Miller CT; Contreras JI; Prescott MS; Dagenais SL; Wu R; Yee J; Orringer MB; Misek DE; Hanash SM; Glover TW; Beer DG
    Cancer Res; 2002 Sep; 62(18):5273-9. PubMed ID: 12234996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite roles of FOXA1 and NKX2-1 in lung cancer progression.
    Deutsch L; Wrage M; Koops S; Glatzel M; Uzunoglu FG; Kutup A; Hinsch A; Sauter G; Izbicki JR; Pantel K; Wikman H
    Genes Chromosomes Cancer; 2012 Jun; 51(6):618-29. PubMed ID: 22383183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
    Staaf J; Isaksson S; Karlsson A; Jönsson M; Johansson L; Jönsson P; Botling J; Micke P; Baldetorp B; Planck M
    Int J Cancer; 2013 May; 132(9):2020-31. PubMed ID: 23023297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing the cancer genome in lung adenocarcinoma.
    Weir BA; Woo MS; Getz G; Perner S; Ding L; Beroukhim R; Lin WM; Province MA; Kraja A; Johnson LA; Shah K; Sato M; Thomas RK; Barletta JA; Borecki IB; Broderick S; Chang AC; Chiang DY; Chirieac LR; Cho J; Fujii Y; Gazdar AF; Giordano T; Greulich H; Hanna M; Johnson BE; Kris MG; Lash A; Lin L; Lindeman N; Mardis ER; McPherson JD; Minna JD; Morgan MB; Nadel M; Orringer MB; Osborne JR; Ozenberger B; Ramos AH; Robinson J; Roth JA; Rusch V; Sasaki H; Shepherd F; Sougnez C; Spitz MR; Tsao MS; Twomey D; Verhaak RG; Weinstock GM; Wheeler DA; Winckler W; Yoshizawa A; Yu S; Zakowski MF; Zhang Q; Beer DG; Wistuba II; Watson MA; Garraway LA; Ladanyi M; Travis WD; Pao W; Rubin MA; Gabriel SB; Gibbs RA; Varmus HE; Wilson RK; Lander ES; Meyerson M
    Nature; 2007 Dec; 450(7171):893-8. PubMed ID: 17982442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival.
    Perner S; Wagner PL; Soltermann A; LaFargue C; Tischler V; Weir BA; Weder W; Meyerson M; Giordano TJ; Moch H; Rubin MA
    J Pathol; 2009 Jan; 217(1):65-72. PubMed ID: 18932182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer.
    Hsu DS; Acharya CR; Balakumaran BS; Riedel RF; Kim MK; Stevenson M; Tuchman S; Mukherjee S; Barry W; Dressman HK; Nevins JR; Powers S; Mu D; Potti A
    Proc Natl Acad Sci U S A; 2009 Mar; 106(13):5312-7. PubMed ID: 19279207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homeobox gene HOP has a potential tumor suppressive activity in human lung cancer.
    Chen Y; Pacyna-Gengelbach M; Deutschmann N; Niesporek S; Petersen I
    Int J Cancer; 2007 Sep; 121(5):1021-7. PubMed ID: 17417779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
    Gorgoulis VG; Kotsinas A; Zacharatos P; Mariatos G; Liloglou T; Tsoli E; Kokotas S; Fassoulas C; Field JK; Kittas C
    Cancer; 2000 Nov; 89(9):1933-45. PubMed ID: 11064350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer.
    Luo ZG; Tang H; Li B; Zhu Z; Ni CR; Zhu MH
    Oncol Rep; 2011 Apr; 25(4):1073-81. PubMed ID: 21286670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers.
    Onozato R; Kosaka T; Kuwano H; Sekido Y; Yatabe Y; Mitsudomi T
    J Thorac Oncol; 2009 Jan; 4(1):5-11. PubMed ID: 19096300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX2 amplification is a common event in squamous cell carcinomas of different organ sites.
    Maier S; Wilbertz T; Braun M; Scheble V; Reischl M; Mikut R; Menon R; Nikolov P; Petersen K; Beschorner C; Moch H; Kakies C; Protzel C; Bauer J; Soltermann A; Fend F; Staebler A; Lengerke C; Perner S
    Hum Pathol; 2011 Aug; 42(8):1078-88. PubMed ID: 21334718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of loss of heterozygosity in small adenocarcinomas of the lung.
    Yoshioka H; Takeuchi T; Matsuno Y; Yamada T; Shimosato Y; Hirohashi S; Noguchi M
    Jpn J Clin Oncol; 1998 Apr; 28(4):240-4. PubMed ID: 9657008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2.
    Cardnell RJ; Behrens C; Diao L; Fan Y; Tang X; Tong P; Minna JD; Mills GB; Heymach JV; Wistuba II; Wang J; Byers LA
    Clin Cancer Res; 2015 Aug; 21(15):3480-91. PubMed ID: 25878335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between morphological heterogeneity and genetic alteration within one tumor in adenocarcinomas of the lung.
    Yamasaki M; Takeshima Y; Fujii S; Matsuura M; Tagawa K; Inai K
    Pathol Int; 2000 Nov; 50(11):891-6. PubMed ID: 11107065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
    Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
    Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
    Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
    Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor-1α polymorphisms are associated with genetic aberrations in lung cancer.
    Putra AC; Tanimoto K; Arifin M; Hiyama K
    Respirology; 2011 Jul; 16(5):796-802. PubMed ID: 21435097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the genetic alterations in two epithelial collision tumors of the uterine cervix. A report of two cases.
    Kersemaekers AM; van de Vijver MJ; Fleuren GJ
    Int J Gynecol Pathol; 2000 Jul; 19(3):225-30. PubMed ID: 10907170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.